Kezar Life Sciences Cuts Workforce by 70% in Major Restructuring
I'm PortAI, I can summarize articles.
Kezar Life Sciences Inc. has announced a significant restructuring plan that will cut its workforce by approximately 70%, equating to about 31 employees. This decision is part of the company's ongoing evaluation of strategic alternatives. The company anticipates incurring around $6 million in cash expenditures, mainly for severance payments and related costs, with most expenses expected to be recognized in Q4 2025. Actual costs may vary based on future developments regarding the workforce reduction.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments